Categories: Cleantech

Finavera shores up finances with $22-million sale to Innergex


Finavera CEO Jason Bak says the Wildmare transaction validates the company’s business model and could be replicated across its entire BC portfolio.

Finavera Wind Energy (TSXV:FVR) today announced it had signed a binding purchase and sale agreement to sell its 77-megawatt Wildmare wind energy project for approximately $22-million to Innergex Renewable Energy (TSX:INE).

Finavera CEO Jason Bak said: “We are extremely pleased to sign this agreement with Innergex for the sale of the Wildmare wind energy project.” He added: “This transaction illustrates the significant asset value Finavera has created for shareholders and provides a strong return on our investment in the development of wind energy for British Columbia. This transaction creates a stable platform for long-term growth and allows Finavera to recycle capital and fund the ongoing development of its remaining portfolio of projects.”

_____________________________

This story is brought to you by Cantech Letter sponsor BIOX (TSX:BX). The largest producer of biodiesel in Canada, BIOX’s proprietary production process has the capability to use a variety of feedstock, including recycled vegetable oils, agricultural seed oils, yellow greases and tallow. For more information CLICK HERE.

_______________________________

Finavera, which is headquartered in Vancouver, was actually founded in Dublin in 2003. The company is now decidedly Canadian, with four wind projects in Canada compared to just one in Ireland, a 105 MW project on that country’s west coast. In February of last year, The company made a deal with GE Energy Financial Services that would see GE invest $40 million in the Wildmare project that Finavera planned to build near Chetwynd, BC. Finavera says it is in talks with GE on partnering on its other wind farms, including Tumbler Ridge, the 117-megawatt Meikle, and the 60-megawatt Bullmoose project.

The transaction will shore up Finavera’s tentative books. The company lost $3.24 million in 2011 and its cash position had dwindled to just $41,209 as of March 31st, 2012.

Bak says the transaction serves as a reminder of Finavera’s business model, which is to take projects from development stage to advanced permitting, where it determines whether to sell the project or finance and construct it themselves. With today’s sale double Finavera’s current market cap, Bak says the transaction validates the company’s business and could be replicated across its entire BC portfolio. Shareholders will be watching Tunbler Ridge closely. In April, Finavera received environmental approval for the 49.6-megawatt wind project.

At press time, share of Finavera were up 34% to $.295 cents.

_________________________

_________________________

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: fvrine
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

10 hours ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

11 hours ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

1 day ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

1 day ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

2 days ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

4 days ago